Ledger.Open graph →
SEC Form D · filed November 18, 2011

Abide Therapeutics, Inc

Offering
$2.3M
Sold
$2.2M
Exemption
—
Industry
Pharmaceuticals
Location
PRINCETON, NJ
Type
—

People & firms on this filing (7)

Alan Ezekowitz · Princeton, NJExec · DirectorJohn Clarke · Halifax, Nova Scotia, CanadaDirectorPaul Schimmel · Princeton, NJDirectorAlan Ezekowitz · Cambridge, MAExec · DirectorJohn Clarke · Houston, TXDirectorBenjamine Cravatt · Princeton, NJDirectorPaul Schimmel · Research Triangle Park, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗